Drug Overview
The NDC code 51407-0053 corresponds to Carvedilol Phosphate, a medication manufactured by Golden State Medical Supply, Inc. Carvedilol is a beta-blocker used primarily to treat high blood pressure and heart failure.
Current Pricing
As of the latest available data, the Wholesale Acquisition Cost (WAC) for Carvedilol Phosphate under the NDC 51407-0053 is not explicitly stated in the provided sources. However, we can look at similar formulations to gauge the pricing trend.
For instance, Carvedilol Phosphate tablets from various manufacturers are generally priced in the range of $0.10 to $0.30 per unit, depending on the dosage and packaging[1].
Market Trends
Several key trends in the pharmaceutical industry are likely to influence the pricing and market dynamics of Carvedilol Phosphate:
Drug Price Inflation
Vizient, Inc. projects a 3.8% increase in drug prices for 2024, driven partly by specialty pharmaceuticals. While this projection is more relevant to specialty drugs, it indicates a broader trend of rising drug costs that could affect all segments, including generic medications like Carvedilol Phosphate[3].
Generic and Biosimilar Competition
The market share of generic drugs and biosimilars is expected to grow. For example, biosimilars made up 24.93% of purchasing volume for originator products and their corresponding biosimilars in 2023 and are expected to increase their market share in 2024. This competition could potentially stabilize or reduce prices for generic medications[3].
Regulatory and Patent Landscape
The life sciences industry is facing a significant loss of exclusivity due to expiring patents, which could lead to increased competition from generics and biosimilars. This trend might affect the pricing strategy for drugs like Carvedilol Phosphate, as manufacturers may need to adjust prices to remain competitive[5].
Price Projections
Given the current market trends:
Short-Term Projections
For 2024 and 2025, the price of Carvedilol Phosphate (NDC 51407-0053) is likely to remain relatively stable or experience a modest increase, aligning with the overall 3.8% drug price inflation projected by Vizient. This increase would be driven more by general market conditions rather than specific changes in the demand or supply of Carvedilol Phosphate.
Long-Term Projections
In the long term, the impact of increasing generic and biosimilar competition could lead to price stabilization or even a slight decrease. As more manufacturers enter the market with their versions of Carvedilol Phosphate, the competitive pressure is likely to keep prices in check.
Impact of Technological Advancements
While technological advancements like AI and gene editing are revolutionizing the pharmaceutical industry, their immediate impact on the pricing of established generic drugs like Carvedilol Phosphate is likely to be minimal. These technologies are more significant for new drug development and personalized medicine rather than affecting the pricing dynamics of existing generic medications[2].
Consumer and Healthcare Provider Perspectives
Consumers and healthcare providers are increasingly demanding personalized care and cost-effective treatments. This demand could influence the market dynamics, pushing manufacturers to maintain competitive pricing to ensure market share. However, for a well-established generic drug like Carvedilol Phosphate, the pricing is already competitive, and significant changes are unlikely in the near future[5].
Key Takeaways
- Current Pricing: The WAC for Carvedilol Phosphate (NDC 51407-0053) is expected to be in line with other generic formulations, typically ranging from $0.10 to $0.30 per unit.
- Short-Term Projections: A modest increase in price, aligning with the 3.8% drug price inflation projected for 2024.
- Long-Term Projections: Potential price stabilization or slight decrease due to increased competition from generics and biosimilars.
- Technological Impact: Minimal immediate impact from technological advancements on the pricing of established generic drugs.
- Market Dynamics: Competitive pricing will be maintained to meet consumer and healthcare provider demands for cost-effective treatments.
FAQs
Q: What is the current Wholesale Acquisition Cost (WAC) for Carvedilol Phosphate (NDC 51407-0053)?
A: The exact WAC for this specific NDC is not provided in the sources, but similar formulations are priced between $0.10 to $0.30 per unit.
Q: How will the 3.8% drug price inflation affect Carvedilol Phosphate?
A: It is likely to result in a modest price increase, aligning with the overall market trend.
Q: Will technological advancements like AI impact the pricing of Carvedilol Phosphate?
A: No, these advancements are more relevant to new drug development and personalized medicine, not directly affecting established generic drugs.
Q: How will increased competition from generics and biosimilars affect the price of Carvedilol Phosphate?
A: It could lead to price stabilization or a slight decrease in the long term.
Q: What are the key factors influencing the pricing of Carvedilol Phosphate in 2025?
A: Market trends, regulatory changes, patent expirations, and consumer demand for cost-effective treatments.
Cited Sources
- Nevada Drug Transparency 2024 Drug Lists - Nevada Department of Health and Human Services
- The Future of Pharma: 2025's Key Trends To Know - Laboratorios Rubio
- Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient, Inc.
- Golden State Medical Supply, Inc. - List of Drugs - NDC Labeler - FindACode
- 2025 life sciences outlook - Deloitte Insights
